Related references
Note: Only part of the references are listed.Rho-kinase ROCK inhibitors reduce oligomeric tau protein
Tadanori Hamano et al.
NEUROBIOLOGY OF AGING (2020)
Severity of subjective forgetfulness is associated with high dietary intake of copper in Japanese senior women: A cross- sectional study
Tamami Odai et al.
FOOD SCIENCE & NUTRITION (2020)
Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization
Norimichi Shirafuji et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease
David I. Finkelstein et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Pioglitazone prevents tau oligomerization
Tadanori Hamano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Folic acid inhibits tau phosphorylation through regulation of PP2A methylation in SH-SY5Y cells
W. Li et al.
JOURNAL OF NUTRITION HEALTH & AGING (2015)
TOC1: A valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy
Sarah M. Ward et al.
NEUROBIOLOGY OF DISEASE (2014)
Zinc Binding Directly Regulates Tau Toxicity Independent of Tau Hyperphosphorylation
Yunpeng Huang et al.
CELL REPORTS (2014)
Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation
Yan Xiong et al.
NEUROBIOLOGY OF AGING (2013)
Characteristics of tau oligomers
Yan Ren et al.
FRONTIERS IN NEUROLOGY (2013)
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
Cristian A. Lasagna-Reeves et al.
FASEB JOURNAL (2012)
Synaptic Released Zinc Promotes Tau Hyperphosphorylation by Inhibition of Protein Phosphatase 2A (PP2A)
Xu-Ying Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The role of metallobiology and amyloid-ss peptides in Alzheimer's disease
Blaine R. Roberts et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Pitavastatin decreases tau levels via the inactivation of Rho/ROCK
Tadanori Hamano et al.
NEUROBIOLOGY OF AGING (2012)
Genetic Inhibition of Solute-Linked Carrier 39 Family Transporter 1 Ameliorates Aβ Pathology in a Drosophila Model of Alzheimer's Disease
Minglin Lang et al.
PLOS GENETICS (2012)
Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease
Kristina R. Patterson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Zinc stimulates tau S214 phosphorylation by the activation of Raf/mitogen-activated protein kinase-kinase/extracellular signal-regulated kinase pathway
Insook Kim et al.
NEUROREPORT (2011)
Novel drug targets based on metallobiology of Alzheimer's disease
Sanghamitra Bandyopadhyay et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Noel G. Faux et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Evidence for Participation of Aluminum in Neurofibrillary Tangle Formation and Growth in Alzheimer's Disease
J. R. Walton
JOURNAL OF ALZHEIMERS DISEASE (2010)
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
Eva Kickstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GCN2 Protein Kinase Is Required to Activate Amino Acid Deprivation Responses in Mice Treated with the Anti-cancer Agent L-Asparaginase
Piyawan Bunpo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322
Zhong-Ying Mo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease
Andreana C. Leskovjan et al.
NEUROIMAGE (2009)
Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation
Peter J. Crouch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structural characterization of binding of Cu(II) to Tau protein
Alice Soragni et al.
BIOCHEMISTRY (2008)
Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3β is required for tau aggregation
Naruhiko Sahara et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression
Tadanori Hamano et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ
Paul A. Adlard et al.
NEURON (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
Jeffrey L. Cummings et al.
NEUROLOGY (2006)
Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: A novel excitoprotective mechanism involving modulation of tau phosphorylation
P Han et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease
AL Guillozet-Bongaarts et al.
NEUROBIOLOGY OF AGING (2005)
Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid β peptide
B Raman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intracellular retention of caveolin 1 in presenilin-deficient cells
DR Wood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban
M Konagaya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease
C Treiber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK)
H Yoshida et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice
I Ferrer
NEUROTOXICITY RESEARCH (2004)
Alzheimer's missing link?
[Anonymous]
MOLECULAR THERAPY (2003)
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
TC Gamblin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The metallobiology of Alzheimer's disease
AI Bush
TRENDS IN NEUROSCIENCES (2003)
Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures
JT Egaña et al.
BIOMETALS (2003)
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease - A pilot phase 2 clinical trial
CW Ritchie et al.
ARCHIVES OF NEUROLOGY (2003)
Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility
N Sahara et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Treatment of Alzheimer's disease with clioquinol
B Regland et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2001)
Tauopathy in Drosophila:: Neurodegeneration without neurofibrillary tangles
CW Wittmann et al.
SCIENCE (2001)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
Characterization of copper interactions with Alzheimer amyloid β peptides:: Identification of an attomolar-affinity copper binding site on amyloid β1-42
CS Atwood et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinol
MS Yassin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Share Paper
